CDK5 and neoplasm: The depletion of CDK5 in medulloblastoma xenograft model resulted in diminished PD-L1 expression and increased the numbers of CD4+ tumour-infiltrating lymphocytes, resulting in robust CD4+ T-cell-mediated tumour rejection [83].